Showing results (1541-1550 of 2,856) with videos related to

Sort By:
Pageof 286
Science (New York, N.Y.)|October 9, 1999
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responsesJ Uchida, T Yasui, Y Takaoka-Shichijo, et al.
NMR in Biomedicine|October 3, 2002
Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumorsSebastian Herminghaus, Ulrich Pilatus, Walter Möller-Hartmann, et al.
Intervirology|January 1, 1993
Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammationR Kandolf, K Klingel, R Zell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitorPing Lu, Michael L Schrag, Donald E Slaughter, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 6, 1998
The role of the general practitioner in the community care of people with HIV infection and AIDS: a comparative study of high- and low-prevalence areas in EnglandM King, R Petchey, S Singh, et al.
International Endodontic Journal|July 14, 2005
Microhardness changes in dentine after neonatal capsaicin applicationT L Krage, A Stiefel, B M Stephan, et al.
Human Pathology|January 26, 2005
Recommendations for the reporting of tissues removed as part of the surgical treatment of malignant liver tumorsDavid J Dabbs, Kim R Geisinger, Francesca Ruggiero, et al.
Protein Science : a Publication of the Protein Society|April 21, 2005
Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activityHenry R Maun, Charles Eigenbrot, Helga Raab, et al.
International Journal of Dermatology|February 26, 2013
Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort studyGabriele Schubert-Fritschle, Anne Schlesinger-Raab, Rüdiger Hein, et al.
International Journal of Molecular Sciences|September 23, 2022
Sequential Targeting of PLK1 and PARP1 Reverses the Resistance to PARP Inhibitors and Enhances Platin-Based Chemotherapy in BRCA-Deficient High-Grade Serous Ovarian Cancer with KRAS AmplificationKhayal Gasimli, Monika Raab, Morva Tahmasbi Rad, et al.
Pageof 286